Welcome to Medications.com

Shire Profit Triples on Sales of Vyvanse ADHD Drug (Update3) - Bloomberg

The company needs to reduce its reliance on hyperactivity drug Adderall XR, which makes up half of its revenue and loses patent protection next year. ...

http://www.bloomberg.com/apps/new... | Posted: Thu Feb 21 12:23:49 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea